SCHEMBL6169314

SCHEMBL6169314

CCOC(=O)c1ccc([N+](=O)[O-])c(N(Cc2ccccc2-c2ccccc2)C(C)=O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.45
ALDH1A1 P00352 5/20 0.44
POLB P06746 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.43
MAPT P10636 5/20 0.42
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
PKM P14618 2/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
PDCD1 Q15116 3/20 0.41
CD274 Q9NZQ7 3/20 0.41
PTGER4 P35408 1/20 0.40
MAPK1 P28482 1/20 0.40
THRB P10828 1/20 0.39
CYP2D6 P10635 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170395 0.88 KMT2A (0.48) KMT2AALDH1A1POLBKDM4EMEN1
SCHEMBL6170389 0.86 KMT2A (0.48) KMT2AALDH1A1POLBKDM4EMEN1
SCHEMBL6169177 0.86 MAPT (0.50) KMT2AALDH1A1POLBKDM4EMEN1
SCHEMBL6171240 0.85 ALDH1A1 (0.48) KMT2AALDH1A1POLBKDM4EMEN1
SCHEMBL6170458 0.85 KMT2A (0.42) KMT2AALDH1A1POLBKDM4EMEN1
SCHEMBL6168155 0.84 KMT2A (0.44) KMT2AALDH1A1POLBKDM4EMEN1
SCHEMBL6171235 0.83 KMT2A (0.42) KMT2AALDH1A1POLBKDM4EMEN1
SCHEMBL6172055 0.83 KMT2A (0.58) KMT2AALDH1A1POLBKDM4EMEN1
SCHEMBL6170132 0.81 KMT2A (0.41) KMT2AALDH1A1POLBKDM4EMEN1
SCHEMBL6170467 0.80 KMT2A (0.52) KMT2AALDH1A1POLBKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed